Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 458 JPY 2.46% Market Closed
Market Cap: 35.4B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fuji Pharma Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Cash from Investing Activities
-ÂĄ911m
CAGR 3-Years
32%
CAGR 5-Years
37%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Investing Activities
-ÂĄ368.6B
CAGR 3-Years
N/A
CAGR 5-Years
32%
CAGR 10-Years
-12%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Investing Activities
-ÂĄ201.2B
CAGR 3-Years
N/A
CAGR 5-Years
-45%
CAGR 10-Years
-16%
Otsuka Holdings Co Ltd
TSE:4578
Cash from Investing Activities
-ÂĄ406.7B
CAGR 3-Years
-107%
CAGR 5-Years
-49%
CAGR 10-Years
-15%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Investing Activities
-ÂĄ37.3B
CAGR 3-Years
36%
CAGR 5-Years
9%
CAGR 10-Years
-7%
Astellas Pharma Inc
TSE:4503
Cash from Investing Activities
-ÂĄ872.9B
CAGR 3-Years
-127%
CAGR 5-Years
-72%
CAGR 10-Years
-42%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
35.4B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 002.38 JPY
Undervaluation 27%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-911m JPY

Based on the financial report for Jun 30, 2024, Fuji Pharma Co Ltd's Cash from Investing Activities amounts to -911m JPY.

What is Fuji Pharma Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
8%

Over the last year, the Cash from Investing Activities growth was 76%. The average annual Cash from Investing Activities growth rates for Fuji Pharma Co Ltd have been 32% over the past three years , 37% over the past five years , and 8% over the past ten years .

Back to Top